You are here: Home » International » News » Economy
Business Standard

Glycine from India, China hurting US biz, anti-dumping duty to be issued

The United States International Trade Commission (USITC) determined that glycine was sold in the US at less than fair value and imports that are subsidised by the governments of China and India.

Press Trust of India  |  Washington 

pharma, chemicals
Representative Image

Import of glycine from India, and is hurting the US industry as the product is sold at less than fair value in America, a federal body has claimed.

The Commission (USITC) said it had determined the US industry was materially injured by imports of glycine from and

It also determined that glycine was sold in the US at less than fair value and imports that are subsidised by the governments of and

As a result of the USITC's affirmative determinations, US Department of Commerce will issue antidumping duty orders on imports of this product from and and countervailing duty orders on imports of it from and India, an official statement said on Wednesday.

USUITC Chairman David Johanson and Commissioners Irving Williamson, Meredith Broadbent, Rhonda Schmidtlein and Jason Kearns voted in the affirmative, according to an official statement.

US import of glycine from China, India, and Japan in 2017 was valued USD 18.6 million. Its import from was USD 4.6 million and from all other sources was USD 480,000.

China, India, Japan and are the leading source of import of glycine.

Glycine, also known as aminoacetic acid, is a nonessential amino acid. The organic chemical is produced naturally by humans and other organisms as a building block for proteins.

Commercial production of glycine uses traditional chemical synthesis. Glycine is commonly sold in its dry form as a white, free flowing powder.

Available in various grades, glycine is used in industrial applications, as well as pharmaceutical and food applications.

First Published: Thu, May 30 2019. 08:05 IST
RECOMMENDED FOR YOU